REFERENCES
- Higley J, Hasert M, Suomi S, et al, The serotonin reuptake inhibitor sertraline reduces excessive alcohol consumption in nonhuman primates: effect of stress. Neuropsychopharmacology. 1998; 8: 431–443
- Myers RD, Quarfordt SD. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response?. Pharmacol Biochem Behav. 1991; 40: 923–928. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Naranjo CA, Sellers EM, Lawrin MO. Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry. 1986; 47((Suppl))16–22. [PUBMED], [INFOTRIEVE]
- Naranjo CA, Sellers EM, Roach CA, et al, Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther. 1984; 35: 374–381. [PUBMED], [INFOTRIEVE]
- Naranjo CA, Sellers EM, Sullivan JT, et al, The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther. 1987; 41: 266–274. [PUBMED], [INFOTRIEVE]
- Naranjo CA, Sullivan JT, Kadlec KE, et al, Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther. 1989; 46: 301–309. [PUBMED], [INFOTRIEVE]
- Naranjo CA, Poulos CX, Bremner KE, et al, Citalopram decreases desirability, liking, and consumption of alcohol in alcohol- dependent drinkers. Clin Pharmacol Ther. 1992; 51: 729–739. [PUBMED], [INFOTRIEVE]
- Kabel DI, Petty F. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment. Alcohol Clin Exp Res. 1996; 20: 780–784. [PUBMED], [INFOTRIEVE]
- Kranzler HR, Burleson JA, Korner P, et al, Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry. 1995; 152: 391–397. [PUBMED], [INFOTRIEVE]
- Gorelick DA, Paredes A. Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res. 1992; 16: 261–265. [PUBMED], [INFOTRIEVE]
- Cornelius JR, Salloum IM, Ehler JG, et al, Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1997; 54: 700–705. [PUBMED], [INFOTRIEVE]
- Pettinati HM. Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence. Alcohol Clin Exp Res. 1996; 20((7 Suppl))23A–29A. [PUBMED], [INFOTRIEVE]
- Kranzler HR, Burleson JA, Brown J, et al, Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res. 1996; 20: 1534–1541. [PUBMED], [INFOTRIEVE]
- Babor TF, Hofmann M, DelBoca FK, et al, Types of alcoholics: I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry. 1992; 49: 599–608. [PUBMED], [INFOTRIEVE]
- Pettinati HM, Volpicelli JR, Kranzler HR, et al, Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res. 2000; 24: 1041–1049. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hesselbrock MN. Gender comparison of antisocial personality disorder and depression in alcoholism. J Subst Abuse. 1991; 3: 205–219. [PUBMED], [INFOTRIEVE]
- Wilsnack SC, Wilsnack RW. Drinking and problem drinking in US women: patterns and recent trends. Recent Dev Alcohol. 1995; 12: 29–60. [PUBMED], [INFOTRIEVE]
- Pettinati HM, Pierce JD, Jr., Wolf AL, et al, Gender differences in comorbidly depressed alcohol-dependent outpatients. Alcohol Clin Exp Res. 1997; 21: 1742–1746. [PUBMED], [INFOTRIEVE]
- Pettinati HM, Rukstalis MR, Luck GJ, et al, Gender and psychiatric comorbidity: impact on clinical presentation of alcohol dependence. Am J Addict. 2000; 9: 242–252. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Baraona E, Abittan CS, Dohmen K, et al, Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001; 25: 502–507. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kessler RC, Crum RM, Warner LA, et al, Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997; 54: 313–321. [PUBMED], [INFOTRIEVE]
- Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988; 49: 219–224. [PUBMED], [INFOTRIEVE]
- Naranjo CA, Knoke DM, Bremner KE. Variations in response to citalopram in men and women with alcohol dependence. J Psychiatry Neurosci. 2000; 25: 269–275. [PUBMED], [INFOTRIEVE]
- Spitzer RL, Williams BW, Gibbon M, et al, The structured clinical interview for DSM-III-R (SCID): 1. history, rationale, and description. Arch Gen Psychiatry. 1992; 49: 624–629. [PUBMED], [INFOTRIEVE]
- Pettinati HM, Volpicelli JR, Luck G, et al, Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol. 2001; 21: 143–153. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nowinski J, Baker S, Carroll K. Twelve-step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Rockville, MD, U.S. Department of Health and Human Services. 1995
- Sobell L, Sobell M. Timeline Follow-back: A Technique for Assessing Self-reported Alcohol Consumption. Totowa, NJ, The Humana Press. 1992
- Hamilton M.. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56–62. [PUBMED], [INFOTRIEVE]
- Spitzer RL, Williams JB, Gibbon M. Structural Clinical Interview for DSM-III-R Non-Patient Version (SCID-NP-V). New York, New State Psychiatric Institute, Biometrics Research Department. 1987
- Kornstein SG, Schatzberg AF, Thase ME, et al, Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000; 157: 1445–1452. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet. 1997; 32(Suppl 1)22–30. [PUBMED], [INFOTRIEVE]